A localized salt-dependent aquagenic urticaria successfully treated with omalizumab.
Clin Exp Dermatol
; 47(12): 2339-2341, 2022 Dec.
Article
en En
| MEDLINE
| ID: mdl-36131614
ABSTRACT
We present the first case of a localized salt-dependent aquagenic urticaria confirmed by a challenge test. A good therapeutic response was achieved after only the first dose of omalizumab.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Urticaria
/
Antialérgicos
Tipo de estudio:
Etiology_studies
Límite:
Humans
Idioma:
En
Revista:
Clin Exp Dermatol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Francia